Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Carcinoma × avelumab × NET × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1 Thoracic 1 NET 1 Endocrine 1 Dermatologic 1

Conditions

Neuroendocrine Tumors 4 Carcinoma, Merkel Cell 2 Neoplasms 1 Carcinoma, Neuroendocrine 1 Carcinoma 1

Interventions

Sunitinib 2 Everolimus 2 repotrectinib 1 pralsetinib 1 pasireotide 1 lutetium Lu 177 dotatate 1 epothilone B 1 cixutumumab 1 avelumab 1 Radiotherapy 1 Octreotide 1 Lutetium-177 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04261855 2025-02-14

GoTHAM

Melanoma and Skin Cancer Trials Limited

Phase 1/2 Recruiting

DermatologicEndocrineNET

Carcinoma, Carcinoma, Merkel Cell, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡